Target intelligence / Profile preview

Non-typeable Haemophilus influenzae surface protein (NTHi surface protein)

Target
NTHi surface protein
Molecular classification
Bacterial outer membrane protein, Adhesin, High-molecular-weight surface protein, Autotransporter (for Hap, Hia, Hsf), Lipoprotein
01

Overview

**Non-typeable Haemophilus influenzae surface proteins** are a diverse group of outer membrane proteins expressed by non-capsulated (non-typeable) Haemophilus influenzae (NTHi). Major representatives include high-molecular-weight (HMW) adhesins (HMW1, HMW2), P5, Hap, and Hia, which mediate bacterial colonization and persistence in the human respiratory tract[1][2][4][5][6][8]. - HMW1 and HMW2 are large surface-exposed proteins directly associated with adherence to distinct epithelial surfaces[4][5][6]. - P5 is a major outer membrane protein essential for resistance to complement-mediated serum killing, binding of complement regulators (C4BP, factor H), and contributing to immune evasion[1][3][7][8]. - Hap (Haemophilus adherence and penetration) is an autotransporter protein with serine protease and adhesive activities, promoting adherence and limited invasion[2][8]. - Hia is a high-molecular-weight non-pilus adhesin found in a subset of NTHi strains, with strong homology to the Hsf protein of encapsulated strains and serving a similar adhesive function when HMW proteins are absent[2][6]. These proteins are proposed as major vaccine and immunotherapy targets due to their surface exposure, crucial role in colonization and immune evasion, and ability to trigger host immune responses[5][8]. However, high genetic variability among NTHi strains, phase variation, and antigenic heterogeneity remain substantial barriers to universal vaccine or therapeutic targeting.

Other names
P5Hap (Haemophilus adherence and penetration)HMW1HMW2HiaHsfProtein EProtein FP4Outer membrane protein P5HMW adhesins
02

Mechanism of action

Potential: Vaccine candidates/antibodies could neutralize adhesive functions, impair colonization, and enhance complement-mediated bactericidal clearance. No approved small molecule or antibody drugs with a defined mechanism of action targeting these proteins as of the current knowledge.

03

Biological functions

Mediates bacterial adherence to host epithelial cellsImmune evasion, including resistance to complement-mediated killingColonization of respiratory tract mucosaBinding to extracellular matrix proteins (e.g., fibronectin)Biofilm formation (minor role)
04

Disease associations

Infection (especially respiratory tract infections, otitis media, COPD exacerbations)Other (as colonization factor in mucosal diseases)
05

Safety considerations

Antigenic variability limits universal vaccine or antibody targetingPotential strain replacement (alteration in NTHi population if targeted)Risk of incomplete protection due to heterogeneity of expressed surface proteins among strains
06

Interacting drugs

None with direct clinical approval identified; surface proteins are being explored as vaccine antigens and experimental antibodies in preclinical/clinical research
07

Biomarkers

Expression levels of surface proteins (P5, HMW1, HMW2, Hap, Hia, etc.) may be used experimentally to characterize strain virulence and may help future patient stratification for vaccine efficacy

Beyond the preview

Go deeper on Non-typeable Haemophilus influenzae surface protein (NTHi surface protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-typeable Haemophilus influenzae surface protein (NTHi surface protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call